Austedo API Manufacturers | Suppliers | Exporters

01

Maithri Drugs

India

BIO Partnering at JPM

Not Confirmed

Maithri Drugs: Dedicated to your API needs.

Contact Supplier

India

Virtual Booth

Digital Content

Deutetrabenazine

About the Company : Maithri Drugs Pvt. Ltd. is a global supplier of Active Pharmaceutical Ingredients (APIs), serving pharmaceutical companies in 60+ countries. Its API portfolio spans antivirals, ant...

Maithri Drugs Pvt. Ltd. is a global supplier of Active Pharmaceutical Ingredients (APIs), serving pharmaceutical companies in 60+ countries. Its API portfolio spans antivirals, antibiotics, ARVs, CNS, and cardiovascular segments. The company operates facilities approved by US FDA, EDQM, Health Canada, and WHO-GMP, supported by multiple global DMFs and Ecovadis recognition. Backed by strong R&D, global patents, and customer-focused practices, Maithri delivers high-quality APIs with regulatory excellence. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.

Corporate PDF

02

HRV Pharma

India

BIO Partnering at JPM

Not Confirmed

HRV Pharma - Market Expansion Leader in Pharmaceuticals.

Contact Supplier

India

Virtual Booth

Digital Content

Deutetrabenazine

About the Company : HRV Pharma is a global manufacturer, seller, and exporter of APIs, intermediates, pellets, food-grade chemicals, food additives, and food ingredients. The company provides sourcing...

HRV Pharma is a global manufacturer, seller, and exporter of APIs, intermediates, pellets, food-grade chemicals, food additives, and food ingredients. The company provides sourcing, manufacturing, and supply services to support partners entering new markets worldwide. HRV Pharma works closely with major pharma and food additive companies and represents over 30 Indian drugmakers, primarily serving Europe, the US, and the Middle East. Headquartered in India, it operates offices in the US, Switzerland, Dubai, Lithuania, and Turkey. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.

03

Omgene Life Sciences Pvt. Ltd

India

BIO Partnering at JPM

Not Confirmed

Omgene: R&D-based biopharmaceutical company with GMP facilities, focused on innovation and high-quality, affordable medicines.

Contact Supplier

India

Virtual Booth

Digital Content

Deutetrabenazine

About the Company : Omgene Life Sciences Pvt. Ltd. is an R&D-driven biopharmaceutical company specializing in biopharmaceuticals, peptides, semi-synthetic, and synthetic actives. As a vertically integ...

Omgene Life Sciences Pvt. Ltd. is an R&D-driven biopharmaceutical company specializing in biopharmaceuticals, peptides, semi-synthetic, and synthetic actives. As a vertically integrated company, we focus on developing high-quality formulations based on in-house-produced actives. With GMP-certified facilities and partnerships with contract manufacturers, we excel in formulation development for injectables, lyophilized injectables, complex generics, and oral peptide delivery systems, ensuring affordable, top-quality medicines. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.

04

Lupin Manufacturing Solutions

India

DCAT Week

Attending

Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

Contact Supplier

India

Virtual Booth

Digital Content

Deutetrabenazine

About the Company : Lupin Manufacturing Solutions (LMS), a wholly owned Lupin subsidiary, offers high-quality APIs and end-to-end CDMO services from R&D to commercial scale. Backed by five decades of ...

Lupin Manufacturing Solutions (LMS), a wholly owned Lupin subsidiary, offers high-quality APIs and end-to-end CDMO services from R&D to commercial scale. Backed by five decades of pharma expertise, LMS combines cost efficiency with regulatory excellence. With world-class sites in Dabhasa and Vizag, and an R&D center in Pune, we deliver integrated, sustainable, and globally compliant solutions that accelerate drug development and reduce environmental impact. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.

Corporate PDF

05

Aurobindo Pharma Limited

India

BIO Partnering at JPM

Not Confirmed

06

Equilife Impurities

India

BIO Partnering at JPM

Not Confirmed

07

Farmhispania

Spain

BIO Partnering at JPM

Not Confirmed

08

Viatris

U.S.A

BIO Partnering at JPM

Not Confirmed

Looking for 1392826-25-3 / Deutetrabenazine API manufacturers, exporters & distributors?

PharmaCompass offers a list of Deutetrabenazine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Deutetrabenazine manufacturer or Deutetrabenazine supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Deutetrabenazine manufacturer or Deutetrabenazine supplier.

PharmaCompass also assists you with knowing the Deutetrabenazine API Price utilized in the formulation of products. Deutetrabenazine API Price is not always fixed or binding as the Deutetrabenazine Price is obtained through a variety of data sources. The Deutetrabenazine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Deutetrabenazine

Synonyms

Dutetrabenazine, P341g6w9nb, Sd-809, (3rs,11brs)-9,10-di((2h3)methoxy)-3-(2-methylpropyl)-1,3,4,6,7,11b-hexahydro-2h-benzo(a)quinolizin-2-one, 2h-benzo(a)quinolizin-2-one, 1,3,4,6,7,11b-hexahydro-9,10-di(methoxy-d3)-3-(2-methylpropyl)-, (3r,11br)-rel-, Sd809

Cas Number

1392826-25-3

Unique Ingredient Identifier (UNII)

P341G6W9NB

About Deutetrabenazine

Deutetrabenazine is a novel, highly selective vesicular monoamine transporter 2 (VMAT2) inhibitor indicated for the management of chorea associated with Huntingtons disease. It is a hexahydro-dimethoxybenzoquinolizine derivative and a deuterated [DB04844]. The presence of deuterium in deutetrabenazine increases the half-lives of the active metabolite and prolongs their pharmacological activity by attenuating CYP2D6 metabolism of the compound. This allows less frequent dosing and a lower daily dose with improvement in tolerability. Decreased plasma fluctuations of deutetrabenazine due to attenuated metabolism may explain a lower incidence of adverse reactions associated with deutetrabenazine. Deutetrabenazine is a racemic mixture containing RR-Deutetrabenazine and SS-Deutetrabenazine. Huntington's disease (HD) is a hereditary, progressive neurodegenerative disorder characterized by motor dysfunction, cognitive decline, and neuropsychiatric disturbances that interfere with daily functioning and significantly reduce the quality of life. The most prominent physical symptom of HD that may increase the risk of injury is chorea, which is an involuntary, sudden movement that can affect any muscle and flow randomly across body regions. Psychomotor symptoms of HD, such as chorea, are related to hyperactive dopaminergic neurotransmission. Deutetrabenazine depletes the levels of presynaptic dopamine by blocking VMAT2, which is responsible for the uptake of dopamine into synaptic vesicles in monoaminergic neurons and exocytotic release. As with other agents for the treatment of neurodegenerative diseases, deutetrabenazine is a drug to alleviate the motor symptoms of HD and is not proposed to halt the progression of the disease. In clinical trials of patients with HD, 12 weeks of treatment of deutetrabenazine resulted in overall improvement in mean total maximal chorea scores and motor signs than placebo. It was approved by FDA in April 2017 and is marketed under the trade name Austedo as oral tablets.

Austedo Manufacturers

A Austedo manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Austedo, including repackagers and relabelers. The FDA regulates Austedo manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Austedo API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Austedo manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Austedo Suppliers

A Austedo supplier is an individual or a company that provides Austedo active pharmaceutical ingredient (API) or Austedo finished formulations upon request. The Austedo suppliers may include Austedo API manufacturers, exporters, distributors and traders.

click here to find a list of Austedo suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Austedo Manufacturers | Traders | Suppliers

We have 8 companies offering Austedo

Get in contact with the supplier of your choice:

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.

Austedo

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

14 API Suppliers

6 USDMF

3 EU WC

7 NDC API

8 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

18 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

17 FDF Dossiers

17 FDA Orange Book

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc

14 SPI Pharma

3 DKSH

1 Boai NKY Pharmaceuticals Ltd

3 Gangwal Healthcare

2 Nanjing Well Pharmaceutical

1 Pfanstiehl

1 Kirsch Pharma

5 Actylis

1 Aeon Procare

2 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 Ashland

21 BASF

5 Corel Pharma Chem

2 DFE Pharma

1 Esteem Industries

2 Finar

10 Gangwal Chemicals

2 Ideal Cures

1 Ingredion Pharma Solutions

5 Kerry

1 Keval Exports

10 Microlex e.U

1 Nanjing Bold Chemical

2 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

2 Novo Excipients

2 Pharmatrans-Sanaq

3 Pluviaendo

2 Prachin Chemical

12 Roquette

7 Seppic

3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

9 Sigachi Industries

2 Silverline Chemicals

1 Valens Pharmachem

2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

43 Fillers, Diluents & Binders

23 Solubilizers

21 Direct Compression

21 Coating Systems & Additives

17 Thickeners and Stabilizers

15 Topical

15 Controlled & Modified Release

14 Granulation

14 Chewable & Orodispersible Aids

14 Parenteral

12 Taste Masking

11 Lubricants & Glidants

10 Co-Processed Excipients

10 Disintegrants & Superdisintegrants

9 Film Formers & Plasticizers

5 Emulsifying Agents

3 Surfactant & Foaming Agents

3 Coloring Agents

2 Rheology Modifiers

2 API Stability Enhancers

DIGITAL CONTENT